Home/Filings/4/0001144204-17-044867
4//SEC Filing

LaFrancesca Saverio 4

Accession 0001144204-17-044867

CIK 0001563665other

Filed

Aug 23, 8:00 PM ET

Accepted

Aug 24, 8:01 AM ET

Size

5.4 KB

Accession

0001144204-17-044867

Insider Transaction Report

Form 4
Period: 2017-08-23
La Francesca Saverio
Chief Medical Officer
Transactions
  • Purchase

    Common Stock

    2017-08-23$0.32/sh+150,000$48,000193,998 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.29 to $0.34, inclusive. The reporting person hereby undertakes to provide to Biostage, Inc., any security holder of Biostage, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.

Issuer

Biostage, Inc.

CIK 0001563665

Entity typeother

Related Parties

1
  • filerCIK 0001641900

Filing Metadata

Form type
4
Filed
Aug 23, 8:00 PM ET
Accepted
Aug 24, 8:01 AM ET
Size
5.4 KB